Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03123055
Title A Study of B-701 in Combination With Atezolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (U22)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors BioClin Therapeutics, Inc.
Indications

transitional cell carcinoma

Therapies

Atezolizumab + Vofatamab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.